These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28582649)

  • 1. Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives.
    Naim MJ; Alam MJ; Nawaz F; Naidu VGM; Aaghaz S; Sahu M; Siddiqui N; Alam O
    Bioorg Chem; 2017 Aug; 73():24-36. PubMed ID: 28582649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
    Naim MJ; Alam O; Alam MJ; Shaquiquzzaman M; Alam MM; Naidu VGM
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents.
    Naim MJ; Alam O; Alam MJ; Hassan MQ; Siddiqui N; Naidu VGM; Alam MI
    Bioorg Chem; 2018 Feb; 76():98-112. PubMed ID: 29169079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
    Nazreen S; Alam MS; Hamid H; Shahar Yar M; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai K
    Arch Pharm (Weinheim); 2015 Jun; 348(6):421-32. PubMed ID: 25900064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.
    Nazreen S; Alam MS; Hamid H; Yar MS; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai KK
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3034-42. PubMed ID: 24890090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
    Avupati VR; Yejella RP; Akula A; Guntuku GS; Doddi BR; Vutla VR; Anagani SR; Adimulam LS; Vyricharla AK
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6442-50. PubMed ID: 22981328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARγ agonists.
    Shukla S; Kumar P; Das N; Moorthy NS; Shrivastava SK; Trivedi P; Srivastava RS
    Med Chem; 2012 Sep; 8(5):834-45. PubMed ID: 22741802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and molecular docking studies of novel 3,5-disubstituted 2,4-thiazolidinediones derivatives.
    Ranjan Srivastava A; Bhatia R; Chawla P
    Bioorg Chem; 2019 Aug; 89():102993. PubMed ID: 31129500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
    Nazreen S; Alam MS; Hamid H; Yar MS; Shafi S; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Ali Y; Kharbanda C; Pillai KK
    Eur J Med Chem; 2014 Nov; 87():175-85. PubMed ID: 25255433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, in-Silico studies and biological evaluation of pyrimidine based thiazolidinedione derivatives as potential anti-diabetic agent.
    Amin S; Sheikh KA; Iqubal A; Ahmed Khan M; Shaquiquzzaman M; Tasneem S; Khanna S; Najmi AK; Akhter M; Haque A; Anwer T; Mumtaz Alam M
    Bioorg Chem; 2023 May; 134():106449. PubMed ID: 36889200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.
    Darwish KM; Salama I; Mostafa S; Gomaa MS; Helal MA
    Eur J Med Chem; 2016 Feb; 109():157-72. PubMed ID: 26774923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted 2-thioxothiazolidin-4-one derivatives showed protective effects against diabetic cataract via inhibition of aldose reductase.
    Huang W; Zhang Y; Liang X; Yang L
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900371. PubMed ID: 32237167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and glucose uptake activity of some novel glitazones.
    Kar K; Krithika U; Mithuna ; Basu P; Santhosh Kumar S; Reji A; Prashantha Kumar BR
    Bioorg Chem; 2014 Oct; 56():27-33. PubMed ID: 24927033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of new dual PPARγ-GPR40 agonists with robust antidiabetic activity: Design, synthesis and in combo drug evaluation.
    Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S; Giles-Rivas D; Alarcón-Aguilar FJ; León-Rivera I; Giacoman-Martínez A; Miranda Pérez E; Almanza-Pérez JC
    Biomed Pharmacother; 2017 Jun; 90():53-61. PubMed ID: 28342366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione.
    Lee HW; Kim BY; Ahn JB; Kang SK; Lee JH; Shin JS; Ahn SK; Lee SJ; Yoon SS
    Eur J Med Chem; 2005 Sep; 40(9):862-74. PubMed ID: 15908051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring.
    Mohammed Iqbal AK; Khan AY; Kalashetti MB; Belavagi NS; Gong YD; Khazi IA
    Eur J Med Chem; 2012 Jul; 53():308-15. PubMed ID: 22575535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Series of Ferulic Acid Amides Reveals Unexpected Peroxiredoxin 1 Inhibitory Activity with in vivo Antidiabetic and Hypolipidemic Effects.
    Yasmin S; Cerchia C; Badavath VN; Laghezza A; Dal Piaz F; Mondal SK; Atlı Ö; Baysal M; Vadivelan S; Shankar S; Siddique MUM; Pattnaik AK; Singh RP; Loiodice F; Jayaprakash V; Lavecchia A
    ChemMedChem; 2021 Feb; 16(3):484-498. PubMed ID: 33030290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel 5-(imidazolyl-methyl) thiazolidinediones as antidiabetic agents.
    Shakour N; Sahebkar A; Karimi G; Paseban M; Tasbandi A; Mosaffa F; Tayarani-Najaran Z; Ghodsi R; Hadizadeh F
    Bioorg Chem; 2021 Oct; 115():105162. PubMed ID: 34314919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocatalytic one pot three component approach: Facile synthesis, characterization, molecular modelling and hypoglycemic studies of new thiazolidinedione festooned quinoline analogues catalyzed by alkaline protease from Aspergillus niger.
    Angajala G; Aruna V; Pavan P; Guruprasad Reddy P
    Bioorg Chem; 2022 Feb; 119():105533. PubMed ID: 34902647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes.
    Yasmin S; Capone F; Laghezza A; Piaz FD; Loiodice F; Vijayan V; Devadasan V; Mondal SK; Atlı Ö; Baysal M; Pattnaik AK; Jayaprakash V; Lavecchia A
    Sci Rep; 2017 Oct; 7(1):14453. PubMed ID: 29089569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.